← Leaderboards
Jinbin Xu
Washington University
$4,195,255
Attributed
$6,570,039
Total exposure
6
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,570,039 · 6
By mechanism
R01$5,236,393 · 2
R21$866,146 · 2
R03$467,500 · 2
Top collaborators
- Guoyan Zhao8 shared
- Buck E Rogers2 shared
Most similar at Washington University
Same institution · by research overlap
- Joel Synes Perlmutter$37,740,662
- Zhude Tu$14,617,536
- Kevin J Black$9,834,192
- Jonathan W. Mink$6,955,322
- Tammie Lee Smith Benzinger$27,265,928
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsNeuron LossDisease ProgressionNeuronsBrainAffectSubstantia Nigra StructureParkinson DiseaseDopaminergic NeuronMicrogliaNerve DegenerationPathway InteractionsMonitorFunctional DisorderDementiaPathologyGene ExpressionAstrocytesInsightNeurodegenerative DisordersCase ControlCognitiveBrain TissueBrain Region
Grant awards (17)
Dissect the mechanisms of selective regional vulnerability in Lewy Body Dementias via comparative snRNA-seq analysis$720,071
R01 · FY2025 · NS
Dissect the mechanisms of selective regional vulnerability in Lewy Body Dementias via comparative snRNA-seq analysis$720,071
R01 · FY2024 · NS
Dissect the mechanisms of selective regional vulnerability in Lewy Body Dementias via comparative snRNA-seq analysis$720,071
R01 · FY2023 · NS
Dissect the mechanisms of selective regional vulnerability in Lewy Body Dementias via comparative snRNA-seq analysis$698,105
R01 · FY2022 · NS
Optimization of imaging mass cytometry, a single-cell spatial proteomics technology, for the study of Alzheimer disease$433,125
R21 · FY2022 · AG
Define molecular events driving selective neuronal death in multiple neurodegenerative diseases by snRNA-seq$157,500
R03 · FY2022 · AG
Dissect the mechanisms of selective regional vulnerability in Lewy Body Dementias via comparative snRNA-seq analysis$710,105
R01 · FY2021 · NS
Small Molecule GPCR Ligands for Oncologic Imaging$236,250
R21 · FY2021 · EB
Define molecular events driving selective neuronal death in multiple neurodegenerative diseases by snRNA-seq$157,500
R03 · FY2021 · AG
POSTMORTEM VALIDATION OF BIOMARKERS FOR IMAGING PARKINSON DISEASE$333,594
R01 · FY2020 · NS · contact PI
Small Molecule GPCR Ligands for Oncologic Imaging$196,771
R21 · FY2020 · EB
POSTMORTEM VALIDATION OF BIOMARKERS FOR IMAGING PARKINSON DISEASE$333,594
R01 · FY2019 · NS · contact PI
POSTMORTEM VALIDATION OF BIOMARKERS FOR IMAGING PARKINSON DISEASE$333,594
R01 · FY2018 · NS · contact PI
POSTMORTEM VALIDATION OF BIOMARKERS FOR IMAGING PARKINSON DISEASE$333,594
R01 · FY2017 · NS · contact PI
POSTMORTEM VALIDATION OF BIOMARKERS FOR IMAGING PARKINSON DISEASE$333,594
R01 · FY2016 · NS · contact PI
DOPAMINE D1, D2, AND D3 RECEPTORS AS BIOMARKERS FOR IMAGING NIGROSTRIATAL NEURONS$76,250
R03 · FY2015 · NS · contact PI
DOPAMINE D1, D2, AND D3 RECEPTORS AS BIOMARKERS FOR IMAGING NIGROSTRIATAL NEURONS$76,250
R03 · FY2014 · NS · contact PI